UNSPSC 85921004: Pharmacotherapy for substance abuse treatment, clonidine

This classification denotes the group of activities that yields a substance abuse treatment intervention or procedure of pharmacotherapy for substance abuse treatment, clonidinepharmacotherapy for substance abuse treatment, clonidine. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code HZ96ZZZ

UNSPSC 85921004 Pharmacotherapy for substance abuse treatment, clonidine is a Commodity code tracking pharmaceutical interventions for addiction management. State and local governments purchase clonidine and related pharmacotherapy under this code to support substance abuse treatment programs, typically as part of broader criminal justice, behavioral health, and community supervision initiatives. Recent state and local solicitations reveal minimal direct purchasing activity under this specific code; instead, procurement activity clusters around the broader service delivery context—substance abuse treatment programs, community corrections, and residential recovery services—rather than the pharmaceutical component itself.

Harris County Community Supervision & Corrections Department issued an RFSQ (Request for Statement of Qualifications) due November 2, 2026, for substance abuse treatment services and cognitive and criminogenic interventions for female offenders in the Women Helping Ourselves Program, with contract performance commencing February 1, 2027. The City of Albuquerque's Department of Health, Housing and Homelessness issued an RFP due May 28, 2026, for the Continuing Sobriety Voucher Pilot Program, a two-year Level-3 recovery housing and supportive services initiative funded through Opioid Settlement Funds, serving up to twenty-five individuals annually exiting substance use treatment and committing to sobriety maintenance—a comprehensive wraparound model that may incorporate pharmacotherapy but does not isolate it. Denton County Community Supervision and Corrections Department requested proposals due June 11, 2026, for in-patient substance abuse treatment services including detoxification and intensive or supportive residential programs. These solicitations target county criminal justice and community corrections bodies across Texas, California, and New Mexico. The code shows limited recent direct commodity-level purchasing; state and local procurement appears structured around integrated treatment service delivery rather than medication procurement line items, suggesting that clonidine and similar agents are procured as components of larger therapeutic service contracts or through pharmacy benefit managers rather than as standalone vendor solicitations.